NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pancreatic Cancer Detection Consortium

RecruitingN/A

Sponsor: City of Hope Medical Center

Conditions: Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms

Interventions: PANcreatic cancer Exosome Early detectiON (PANXEON)

Countries: United States, Japan, South Korea

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
* Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
* Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)

Exclusion Criteria:

* Lack of written informed consent.

Locations (11)

Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Monrovia, California, United States
Newport Beach, California, United States
Peoria, Illinois, United States
Jefferson, Louisiana, United States
Morristown, New Jersey, United States
Rock Hill, South Carolina, United States
Milwaukee, Wisconsin, United States
Nagoya, Japan
Seoul, South Korea